Logo UCA
Icon P.S.

Informations du chercheur

Nom complet

Belbaraka rhizlane

Grade

PES

Spécialité

oncologie

Thématique de recherche

santé

Laboratoire

Laboratoire Biosciences et santé

Établissement

Faculté de Médecine et de Pharmacie de Marrakech

Projets (0 au total)

Aucun projet disponible.

Publications (47 au total)

An Ovarian Intracranial Collision Tumor: A Case Report and Review of the Literature

Auteur: Justin Bagorane, Manon Morillon, Gustave Negamiyimana, Asmahane Benmaziane, Mohamed El Fadli, Philippe Beuzeboc, Bennouna Jaafar, Rhizlane Belbaraka

Revue: Indian Journal of Gynecologic Oncology

Année: 2024

DOI: 10.1007/s40944-024-00856-3

Primary Squamous Carcinoma: A Description of a Rare Histological Type of Breast Cancer

Auteur: Mohamed Kaakoua, Mohamed Amine Haouane, Soukayna Boujmadi, Moussa Abdoul Aziz Sawadogo, Mohamed Amine Azami, Rhizlane Belbaraka, Ismail Essadi

Revue: Cureus

Année: 2024

DOI: 10.7759/cureus.69748

Construction of a Nomogram to Predict the Progression Free Survival in Patients With Lung Cancer

Auteur: Hassan Abdelilah TAFENZI, Farah CHOULLI, Ismail ESSAADI, Rhizlane BELBARAKA

Revue: research square

Année: 2024

DOI: 10.21203/rs.3.rs-4335327/v1

Investigating the outcome of vascular emboli in patients with breast cancer.

Auteur: Tafenzi Hassan Abdelilah, Farah Choulli, Ismail Essadi, Rhizlane Belbaraka

Revue: Journal of Clinical Oncology

Année: 2024

DOI: 10.1200/jco.2024.42.16_suppl.e13116

Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study

Auteur: Farah Choulli, Hassan Abdelilah Tafenzi, Faiçal EL Hattimy, Mohamed Khaled Choulli and Rhizlane Belbaraka

Revue: BMC Cancer

Année: 2023

DOI: https://doi.org/10.1186/s12885-023-11616-5

Lung cancer in middle and Southampton morocco.

Auteur: Hassan Abdelilah Tafenzi, Farah Choulli, Anass Baladi, Ismail Essaadi, Rhizlane Belbaraka

Revue: E Cancer

Année: 2023

DOI: https://doi.org/10.3332/ecancer.2023.1518

Development of a well-defined tool to predict the overall survival in lung cancer patients: an African based cohort

Auteur: Hassan Abdelilah Tafenzi, Farah Choulli, Ganiou Adjade, Anas Baladi, LeilaHassan Abdelilah Tafenzi, Farah Choulli, Ganiou Adjade, Anas Baladi, Leila Afani, Mohammed El Fadli, Ismail Essaadi, Rhizlane Belbaraka

Revue: BMC Cancer

Année: 2023

DOI: 10.1186/s12885-023-11355-7

Construction of a Nomogram to Predict the Progression Free Survival in Patients With Lung Cancer

Auteur: Hassan Abdelilah Tafenzi, Farah Choulli, Anass Baladi, Mohammed El Fadli, Ismail Essaadi, Rhizlane Belbaraka

Revue: Frontiers in Oncology

Année: 2023

DOI: 10.3389/fonc.2023.1303745

Lung cancer in middle and southern Morocco

Auteur: Hassan Abdelilah Tafenzi, Farah Choulli, Anass Baladi, Ismail Essaadi, Rhizlane Belbaraka

Revue: ecancermedicalscience

Année: 2023

DOI: 10.3332/ecancer.2023.1518

Communications (25 au total)

Cancer de la prostate: place du Zoladex à l'ère des nouvelles thérapies

Manifestation: 31ème Congrès National d'Urologie

Date: 2024-05-11

Organisation: Marrakech

Interventional Oncology Trials in Africa Then, Now and Next

Manifestation: AORTIC 2023: Cancer in Africa: Implementation, Workforce, Opportunities

Date: 2023-11-05

Organisation: DAKAR, SENEGAL

Breast Cancer: Improving the Patient Journey in Morocco

Manifestation: AORTIC 2023: Cancer in Africa: Implementation, Workforce, Opportunities

Date: 2023-11-04

Organisation: DAKAR, Senegal

Risk factors, and prognostic factors, for progression free survival in patients with newly diagnosed of lung cancer: a population-based study

Manifestation: Congrès de l' Association Marocaine de Formation et Recherche en Oncologie Médicale

Date: 2023-10-06

Organisation: Tanger

Controversies in Lung Cancer: which second line after platinum based chemotherapy?

Manifestation: Congrès de l'Association Marocaine de Formation et Recherche en Oncologie Médicale

Date: 2023-10-06

Organisation: Tanger

An AI mobile health app for remote support and monitoring of breast cancer patients undergoing chemotherapy (Hna Maak).

Manifestation: 6ème édition Forum Galien

Date: 2023-10-03

Organisation: Dakar- Senegal

Development and validation of a predictive tool for oesophageal cancer patients: A Moroccan-based study.

Manifestation: 25th World Congress on Gastrointestinal Cancer

Date: 2023-06-29

Organisation: Barcelone- Espagne

Nouveautés dans le cancer du sein triple négatif et Her 2 low

Manifestation: 1st Maghreb Summit Astra Zeneca

Date: 2023-02-25

Organisation: Tunis, Tunisie

An AI mobile health app for remote support and monitoring of breast cancer patients undergoing chemotherapy.

Manifestation: 2ème édition du congrès Healthcare et Innovation

Date: 2023-02-23

Organisation: Casablanca